🔎 Trials Near Me

Gara Jalqabaatti › Baayyee Ulfaataa › Massachusetts

Qorannoo klinikaalii Baayyee Ulfaataa Massachusetts keessatti

Qorannoo 24 Baayyee Ulfaataa f Massachusetts keessatti hirmaatuu jiru.

Magaalota Massachusetts keessatti

Takkalaa qorannoo (Ingiliffa)

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Brigham and Womens Hospital, Boston
  • Btc of New Bedford, New Bedford
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Brigham and Women's Hospital Diabetes Program, Boston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Lucida Clinical Trials, New Bedford
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Boston Children's Hospital, Boston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Lucida Clinical Trials, New Bedford
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • Brigham and Women's Hospital Diabetes Program, Boston
  • MedVadis Research Corporation, Waltham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Lucida Clinical Trials, New Bedford
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07282600

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • Skylight Health Research - Burlington, Burlington
  • Care Access - Quincy, Quincy
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • Knownwell, Needham
  • Lucida Clinical Trials, New Bedford
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • Care Access - Quincy, Quincy
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07321886

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, North Dartmouth
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07784270

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Boston Medical Center, Boston
  • Knownwell, Needham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Methuen
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07654374

The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression

  • Massachusetts General Hospital, Boston
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07699445

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • Knownwell, Needham
  • Lucida Clinical Trials, New Bedford
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Boston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07284901

Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity

  • Exponent Boston, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07776678

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Methuen
  • ACCOMPLISH-1 Research Site, Needham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07654361

Family-Based Weight Wellness Treatment Through Food is Medicine and Group Medical Visits in Pediatric and Adult Primary Care

  • Tufts Medical Center, Boston
  • Tufts University, Boston
Namoota walitti qabaa jira
Umuriin 12 hanga 17 · Saalaa hunda · Haaromfame 21-Ado-2026 · NCT07717658

Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food

  • Cambridge Health Alliance, Sommerville
Namoota walitti qabaa jira
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 16-Ado-2026 · NCT06988462

Time Restricted Eating (TRE) in Bipolar Disorder

  • Massachusetts General Hospital, Boston
Namoota walitti qabaa jira
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 15-Wax-2026 · NCT07211217

Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population

  • Massachusetts General Hospital, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 24-Mud-2025 · NCT05799222

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

  • Brigham and Women's Hospital, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Mud-2025 · NCT06069622

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.